These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8549291)

  • 1. The susceptibility of Mycobacterium tuberculosis and atypical mycobacteria in northern Israel.
    Cahana Z; Gabbay R; Raz R
    Drugs; 1995; 49 Suppl 2():171-2. PubMed ID: 8549291
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug resistance in mycobacteria.
    Mitchison DA
    Br Med Bull; 1984 Jan; 40(1):84-90. PubMed ID: 6442876
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of luciferase-reporter phage for antibiotic-susceptibility testing of mycobacteria.
    Riska PF; Jacobs WR
    Methods Mol Biol; 1998; 101():431-55. PubMed ID: 9921495
    [No Abstract]   [Full Text] [Related]  

  • 4. In-vitro susceptibility of mycobacteria to ciprofloxacin.
    Collins CH; Uttley AH
    J Antimicrob Chemother; 1985 Nov; 16(5):575-80. PubMed ID: 2934361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mycobacteria].
    Beer V; Bonifas V
    Schweiz Med Wochenschr; 1975 Aug; 105(31):984-7. PubMed ID: 807970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rapid identification of Mycobacterium tuberculosis complex from broth cultures by immunochromatographic assay].
    García-Martos P; García-Agudo L; Rodríguez-Jiménez MJ; Rodríguez-Iglesias M
    Rev Esp Quimioter; 2010 Dec; 23(4):206-9. PubMed ID: 21191560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro and in vivo activities of norfloxacin, ofloxacin and ciprofloxacin against various mycobacteria].
    Saito H; Sato K; Tomioka H; Watanabe T
    Kekkaku; 1987 May; 62(5):287-94. PubMed ID: 3114537
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro activity of new quinoxalin 1,4-dioxide derivatives against strains of Mycobacterium tuberculosis and other mycobacteria.
    Zanetti S; Sechi LA; Molicotti P; Cannas S; Bua A; Deriu A; Carta A; Paglietti G
    Int J Antimicrob Agents; 2005 Feb; 25(2):179-81. PubMed ID: 15664491
    [No Abstract]   [Full Text] [Related]  

  • 9. Mycobacterial efflux pumps and chemotherapeutic implications.
    Viveiros M; Leandro C; Amaral L
    Int J Antimicrob Agents; 2003 Sep; 22(3):274-8. PubMed ID: 13678834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of the Etest for studying tigecycline susceptibility of non-pigmented rapidly growing mycobacteria.
    Martín-de-Hijas NZ; Fernández-Roblas R; Fernandez-Martínez AI; Gadea I; Esteban J
    Int J Antimicrob Agents; 2008 Oct; 32(4):366-7. PubMed ID: 18572391
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitative structure-activity relationships for the in vitro antimycobacterial activity of pyrazinoic acid esters.
    Bergmann KE; Cynamon MH; Welch JT
    J Med Chem; 1996 Aug; 39(17):3394-400. PubMed ID: 8765523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiometric diagnosis of mycobacteria.
    Laszlo A; Handzel V
    Eur J Clin Microbiol; 1986 Apr; 5(2):152-5. PubMed ID: 3087747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemo-antibiotic-resistance in vitro of "atypical" mycobacteria and Mycobacterium tuberculosis].
    Caroli G; Spaziante G; Mazzarone R
    Riv Ital Ig; 1966; 26(5):535-46. PubMed ID: 4967922
    [No Abstract]   [Full Text] [Related]  

  • 14. [Resistance to antibiotics of mycobacteria of the Province of Cadiz].
    del Rey Calero J; Casal Roman M
    Rev Sanid Hig Publica (Madr); 1971 Jan; 45(1):73-114. PubMed ID: 5006012
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative in vitro activity of the new macrolide A-56268 against mycobacteria.
    Berlin OG; Young LS; Floyd-Reising SA; Bruckner DA
    Eur J Clin Microbiol; 1987 Aug; 6(4):486-7. PubMed ID: 2959472
    [No Abstract]   [Full Text] [Related]  

  • 16. Susceptibility Testing of Antibiotics That Degrade Faster than the Doubling Time of Slow-Growing Mycobacteria: Ertapenem Sterilizing Effect versus Mycobacterium tuberculosis.
    Srivastava S; van Rijn SP; Wessels AM; Alffenaar JW; Gumbo T
    Antimicrob Agents Chemother; 2016 May; 60(5):3193-5. PubMed ID: 26926650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of antimicrobial agents against mycobacteria.
    Casal M; Rodríguez F; Gutierrez J; Ruíz P; Villalba R
    Drugs Exp Clin Res; 1988; 14(12):741-5. PubMed ID: 3150951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation, identification and drug sensitivity pattern of mycobacterial strains isolated from human patients.
    Nain PS; Chandiramani NK; Darg DN
    Indian J Pathol Microbiol; 1987 Jul; 30(3):261-6. PubMed ID: 3130312
    [No Abstract]   [Full Text] [Related]  

  • 19. [Culture and susceptibility testing of mycobacteria with VersaTREK].
    Gravet A; Souillard N; Habermacher J; Moser A; Lohmann C; Schmitt F; Delarbre JM
    Pathol Biol (Paris); 2011 Feb; 59(1):32-8. PubMed ID: 20850229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New active drugs against the tuberculosis bacillus and other mycobacteria].
    de Kantor IN
    Medicina (B Aires); 1986; 46(1):107-12. PubMed ID: 3100907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.